Trial intelligence / Profile preview

Epinephrine vs Omidria for Intraoperative Pupil Size in Cataract Surgery

NCT02895035Phase 4Terminated

Sponsor
Penn State Health Milton S. Hershey Medical Center
Start
Sep 2016
Primary completion
Dec 2018
Modality
Orthosteric Ligands
01

Overview

A Phase 4 trial of phenylephrine + ketorolac in cataract, sponsored by Penn State Health Milton S. Hershey Medical Center. Started Sep 2016; status: terminated.

02

Drugs

phenylephrine + ketorolac
03

Conditions

cataract

Beyond the preview

Go deeper on NCT02895035.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02895035.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call